ABEONA THERAPEUTICS INC. (ABEO) has 7 SEC Form 4 insider filings on record in the last 90 days. No insider purchases were filed — 7 sales totalling $981K. Most recent filing: Sept. 1, 2026.
| Date | Insider | Value | Shares | Stake | Pre-planned | Links |
|---|---|---|---|---|---|---|
| Sept. 1, 2026 | Alvino Mark Director | −$87,966 | 15,000 | −19% | No | |
|
|
||||||
| July 22, 2026 filed July 21, 2026 | Vazzano Joseph Walter Chief Financial Officer | −$9,651 | 1,478 | −0% | No | |
|
|
||||||
| July 9, 2026 | Vazzano Joseph Walter Chief Financial Officer | −$173,257 | 24,880 | −5% | No | |
|
|
||||||
| July 9, 2026 | Seshadri Vishwas Chief Executive Officer | −$473,330 | 67,971 | −5% | No | |
|
|
||||||
| July 9, 2026 | O'Malley Brendan M. SVP, Chief Legal Officer | −$83,913 | 12,050 | −3% | No | |
|
|
||||||
Showing the 5 most recent of 7 filings in the last 90 days.
Form 4 is the filing company officers, directors and 10% shareholders must submit to the SEC within two business days of trading their own company's stock. Open-market purchases generally carry more signal than sales, which are often scheduled in advance. More on how this works.
Real-time Telegram alerts the moment a Form 4 is filed. Filings shown here are delayed by 72 hours.
Start free